Wolverine Asset Management LLC Gilead Sciences, Inc. Put Options Transaction History

Wolverine Asset Management LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $5.19 Million - $6.32 Million	-71,200 Reduced 78.07%	20,000 $1.51 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $3.34 Million - $3.93 Million	47,000 Added 106.33%	91,200 $6.53 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.75 Million - $2.07 Million	24,200 Added 121.0%	44,200 $3.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,000	20,000 $1.42 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.